Keywords
Abstract
Polycystic ovary syndrome is a common endocrine and gynecological disorder affecting women of reproductive age and characterized by reproductive, hormonal, and metabolic abnormalities. The present study evaluated the clinical and hormonal characteristics of women with polycystic ovary syndrome and assessed changes in menstrual function, manifestations of hyperandrogenism, and reproductive outcomes. The study included 50 patients.
Menstrual irregularities, hirsutism, acne, and hormonal disturbances were among the most frequently observed clinical manifestations. Following treatment, menstrual regularity improved, clinical manifestations of hyperandrogenism decreased, and significant changes in hormonal parameters were observed. Pregnancy was achieved in 21 patients during the follow-up period. The findings demonstrate the importance of comprehensive clinical and hormonal assessment and individualized management in women with polycystic ovary syndrome.
References
Teede H.J., Tay C.T., Laven J.J.E., Dokras A., Moran L.J., Piltonen T.T., Costello M.F., Boivin J., Redman L.M., Boyle J.A., Norman R.J., Mousa A., Joham A.E., International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome // European Journal of Endocrinology. 2023. Vol. 189, № 2. P. G43–G64.
Teede H.J., Tay C.T., Laven J.J.E., Dokras A., Moran L.J., Piltonen T.T., Costello M.F., Boivin J., Redman L.M., Boyle J.A., Norman R.J., Mousa A., Joham A.E. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome // Fertility and Sterility. 2023. Vol. 120, № 4. P. 767–793.
Dason E.S., Koshkina O., Chan C., Sobel M. Diagnosis and management of polycystic ovarian syndrome // CMAJ. 2024. Vol. 196, № 3. P. E85–E94.
Myerson M.L., Paparodis R.D., Block R.C., Karalis D.G., Mintz G., Brinton E.A., Wild R. Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention // Journal of Clinical Lipidology. 2024. Vol. 18, № 4. P. e488–e500.
Mousa A., Tay C.T., Teede H.J. Technical Report for the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome: 2023 Update. Australia: Monash University, 2023. 5816 p.
Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L., Piltonen T., Norman R.J., International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome // Human Reproduction. 2018. Vol. 33, № 9. P. 1602–1618.
Escobar-Morreale H.F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment // Nature Reviews Endocrinology. — 2018. Vol. 14. P. 270–284.
Azziz R., Carmina E., Chen Z., Dunaif A., Laven J.S.E., Legro R.S., Lizneva D., Natterson-Horowtiz B., Teede H.J., Yildiz B.O. Polycystic ovary syndrome // Nature Reviews Disease Primers. 2016. Vol. 2.
Lizneva D., Suturina L., Walker W., Brakta S., Gavrilova-Jordan L., Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome // Fertility and Sterility. 2016. Vol. 106, № 1. P. 6–15.
Joham A.E., Teede H.J., Ranasinha S., Zoungas S., Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study // Journal of Women's Health. 2015. Vol. 24, № 4. P. 299–307.